A recent meta-analysis shows that several conditions associated with raised pre-infection plasma C3 levels such as diabetes mellitus are associated with worse clinical outcomes [40]; while during the progress of a COVID-19 infection another meta-analysis showed that worse clinical outcomes are associated with lower C3 levels [41]. This evidence concerns the gene C3 and infection.